Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Rodgers

Showing results (341-350 of 356) with videos related to

Pageof 36
Sort By:
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 7, 2022
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progressCraig S Anderson, Anthony Rodgers, H Asita de Silva, et al.
Diabetologia|July 6, 2021
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.
Diabetologia|August 27, 2021
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.
Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.
Pageof 36

Showing results (341-350 of 356) with videos related to

Sort By:
Pageof 36
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 7, 2022
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progressCraig S Anderson, Anthony Rodgers, H Asita de Silva, et al.
Diabetologia|July 6, 2021
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.
Diabetologia|August 27, 2021
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.
Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.
Pageof 36